Exact Mass: 377.0893

Exact Mass Matches: 377.0893

Found 18 metabolites which its exact mass value is equals to given mass value 377.0893, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Hbgd

6-({[4-(hydroxymethyl)phenyl]methyl}[sulphanyl(carbonothioyl)]amino)hexane-1,2,3,4,5-pentol

C15H23NO6S2 (377.0967)


   

S-Pyruvylglutathione

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-oxopropanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C13H19N3O8S (377.0893)


   

Oxychelirubine

Oxychelirubine

C21H15NO6 (377.0899)


   

12-Hydroxychelirubine

12-Hydroxychelirubine

C21H15NO6 (377.0899)


   

S-Pyruvylglutathione

S-Pyruvylglutathione

C13H19N3O8S (377.0893)


   

Asn-His-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(1H-imidazol-4-yl)butanoic acid

C15H15N5O7 (377.0971)


   

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

tert-Butyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C19H24BrNO2 (377.099)


   

4,4,4-Nitrilotribenzoic acid

4,4,4-Nitrilotribenzoic acid

C21H15NO6 (377.0899)


   
   

Glufanide disodium

Glufanide disodium

C16H17N3Na2O5 (377.0964)


D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D020011 - Protective Agents > D000931 - Antidotes C308 - Immunotherapeutic Agent D007155 - Immunologic Factors

   

2-(4-morpholinyl)-N-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide

2-(4-morpholinyl)-N-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide

C15H15N5O5S (377.0794)


   

N-(1,3-benzodioxol-5-yl)-3-methyl-6-phenyl-2-imidazo[2,1-b]thiazolecarboxamide

N-(1,3-benzodioxol-5-yl)-3-methyl-6-phenyl-2-imidazo[2,1-b]thiazolecarboxamide

C20H15N3O3S (377.0834)


   

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

[2-Amino-6-(2,6-difluoro-benzoyl)-imidazo[1,2-A]pyridin-3-YL]-phenyl-methanone

C21H13F2N3O2 (377.0976)


   

4,5-Dihydrofarnesyl diphosphate

4,5-Dihydrofarnesyl diphosphate

C15H23O7P2-3 (377.0919)


   

S-lactoylgluta-thione

S-lactoylgluta-thione

C13H19N3O8S (377.0893)


   

N-[[4-(dimethylsulfamoyl)anilino]-sulfanylidenemethyl]-2-phenylacetamide

N-[[4-(dimethylsulfamoyl)anilino]-sulfanylidenemethyl]-2-phenylacetamide

C17H19N3O3S2 (377.0868)


   

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

1,3-Benzodioxol-5-yl 4-(diethylsulfamoyl)benzoate

C18H19NO6S (377.0933)


   

Adaptaquin

Adaptaquin

C21H16ClN3O2 (377.0931)


Adaptaquin is an inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PHD2), with an IC50 of 2 μM. Adaptaquin can inhibit lipid peroxidation and maintain mitochondrial function[1][2].